60. 再生不良性貧血 Aplastic anemia Clinical trials / Disease details

臨床試験数 : 245 / 薬物数 : 318 - (DrugBank : 86) / 標的遺伝子数 : 44 - 標的パスウェイ数 : 166

8 trials found

diseases per page:

Showing 1 to 8 of 8 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05323617 (ClinicalTrials.gov)	May 15, 2023	5/4/2022	Efficacy of Romiplostimin Treatment of SAA in Adults Previously Untreated With or Refractory to Immu ...	Two Arm Bridging Study to Evaluate the Efficacy of Romiplostimin the Treatment of Adult Severe Aplas ...	Severe Aplastic Anemia (SAA)	Drug: Romiplostim;Drug: Antithymocyte Globulin;Drug: Cyclosporine A	Amgen	NULL	Not yet recruiting	18 Years	N/A	All	40	Phase 2	NULL
2	NCT04478227 (ClinicalTrials.gov)	August 18, 2020	10/7/2020	TPO-Mimetic Use in Children for Hematopoietic Failure	Single Arm Prospective Open Label Pilot Study Evaluating Short-Term Safety and Efficacy of Romiplost ...	Bone Marrow Failure Disorders;Aplastic Anemia;Thrombocytopenia;Refractory Cytopenia of Childhood;Mye ...	Drug: Romiplostim	Anjali Sharathkumar	Amgen	Recruiting	0 Years	21 Years	All	25	Early Phase 1	United States
3	JPRN-JapicCTI-194962	03/12/2019	18/09/2019	A Phase 2/3 Study of AMG531 in Patients with Aplastic Anemia	A Phase 2/3 Study of AMG531 Combined with Ciclosporin A in Patients with Aplastic Anemia Previously ...	Aplastic Anemia	Intervention name : AMG531 INN of the intervention : romiplostim Dosage And administration of the inte ...	Kyowa Kirin Co., Ltd	NULL	complete	20		BOTH	24	Phase 2-3	Japan, Asia except Japan
4	NCT04095936 (ClinicalTrials.gov)	December 3, 2019	18/9/2019	Study of AMG531 (Romiplostim) in Patients With Aplastic Anemia	A Phase 2/3 Study of AMG531 Combined With Ciclosporin A in Patients With Aplastic Anemia Previously ...	Aplastic Anemia	Drug: Romiplostim	Kyowa Kirin Co., Ltd.	NULL	Completed	20 Years	N/A	All	24	Phase 2/Phase 3	Japan
5	NCT03957694 (ClinicalTrials.gov)	April 25, 2019	9/5/2019	Study of AMG531(Romiplostim) in Patients With Aplastic Anemia	A Phase 2/3 Study of AMG531 in Patients With Aplastic Anemia PreviouslyUntreated With Immunosuppress ...	Aplastic Anemia	Drug: Romiplostim	Kyowa Kirin Co., Ltd.	NULL	Completed	20 Years	N/A	All	17	Phase 2/Phase 3	Japan
6	JPRN-JapicCTI-194746	01/2/2019	09/05/2019	A Phase 2/3 Study of AMG531 in Patients with Aplastic Anemia	A Phase 2/3 Study of AMG531 in Patients with Aplastic Anemia Previously Untreated with Immunosuppres ...	Aplastic Anemia	Intervention name : AMG531 INN of the intervention : romiplostim Dosage And administration of the inte ...	Kyowa Kirin Co., Ltd	NULL	complete	20		BOTH	14	Phase 2-3	Japan, Asia except Japan
7	NCT02773290 (ClinicalTrials.gov)	May 2016	9/5/2016	Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia	Phase 2/3 Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia Refractory to or Ineligible ...	Aplastic Anemia	Biological: Romiplostim	Kyowa Kirin Co., Ltd.	NULL	Completed	20 Years	N/A	All	46	Phase 2/Phase 3	Japan;Korea, Republic of
8	JPRN-JapicCTI-163243	01/2/2016	02/05/2016	Phase 2/3 Study of AMG531 in Subjects with Aplastic Anemia	Phase 2/3 Study of AMG531 in Subjects with Aplastic Anemia Refractory to or Ineligible for Immunosup ...	Aplastic Anemia	Intervention name : AMG531 INN of the intervention : Romiplostim Dosage And administration of the inte ...	Kyowa Hakko Kirin Co., Ltd.	NULL	complete	20		BOTH	46	Phase 2-3	NULL

First Previous1Next Last